RVMD — Revolution Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Revolution Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	577	645	1,853	2,289	2,026
Net Total Accounts Receivable
Net Total Receivables	5.93	4.67	1.25	0	—
Prepaid Expenses
Total Current Assets	590	660	1,879	2,328	2,075
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	71.2	73.7	100	142	165
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	738	812	2,062	2,558	2,355
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	60.4	62	144	164	290
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	135	127	236	293	723
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	603	685	1,826	2,265	1,631
Total Liabilities & Shareholders' Equity	738	812	2,062	2,558	2,355
Total Common Shares Outstanding